Renal transplant recipients have significantly higher mortality than indivi
duals without kidney disease and the excess mortality is mainly due to card
iovascular causes. In this study, we sought to determine the impact of smok
ing, a major cardiovascular risk factor, on patient and renal graft surviva
l. The study population included all adult recipients of first cadaveric ki
dney transplants done in our institution from 1984 to 1991. By selection, a
ll patients were alive and had a functioning graft for at least 1 yr after
transplantation. Smoking history was gathered prior to transplantation. The
follow-up period was 84.3 +/- 41 months and during this time 28% of the pa
tients died and 21% lost their graft. By univariate and multivariate analys
is, patient survival, censored at the time of graft loss, correlated with t
hese pre-transplant variables: age (p < 0.0001); diabetes (p = 0.0002); his
tory of cigarette smoking (p = 0.004); time on dialysis prior to the transp
lant (p = 0.0005); and cardiomegaly by chest X-ray (p = 0.0005). Posttransp
lant variables did not correlate with patient mortality. By Cox regression,
patient survival time was significantly shorter in diabetics (p < 0.0001),
smokers (p = 0.0005), and recipients older than 40 yr. However, there were
no significant differences between the survival of smokers, non-diabetics,
diabetics, and older recipients. Patient death was the most common cause o
f renal transplant failure in smokers, in patients older than 40 yr, and in
diabetics, but these patient characteristics did not correlate with graft
survival. The prevalence of different causes of death was not significantly
different between smokers and non-smokers. In conclusion, a history of cig
arette smoking correlates with decreased patient survival after transplanta
tion, and the magnitude of the negative impact of smoking in renal transpla
nt recipients is quantitatively similar to that of diabetes.